Abstract
6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
G R Breese, G E Duncan, T C Napier, S C Bondy, L C Iorio and R A Mueller
Journal of Pharmacology and Experimental Therapeutics January 1987, 240 (1) 167-176;